Thrombophilia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{Thrombophilia}} {{CMG}} ==Overview=...")
 
No edit summary
Line 5: Line 5:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
==Epidemiology and Demographics==
===Prevalence of various inherited thrombophilias and their clinical impact===
{| border="1" cellpadding="5" cellspacing="0" align="center" class="sortable"
|-
  ! Disorder
  ! Healthy subjects/General population (%)
  ! Patients with known thrombosis (%)
  ! Estimated increase in thrombosis risk
|-
  | [[Antithrombin deficiency]]
  | 0.02
  | 1 - 4
  | 10 - 20X
|-
  | [[Dysfibrinogenemia]]
  | <1
  | <1
  | Variable
|-
  | [[Protein C deficiency]]
  | 0.2 - 0.4
  | 3 - 5
  | 10X
|-
  | [[Protein S deficiency]]
  | 0.3 - 0.13
  | 2 - 4
  | 10X
|-
  | [[Factor V Leiden]]
  | 1 - 15
  | 18 - 40
  | 5X
|-
  | G20210A [[prothrombin]] gene mutation
  | 2 - 5
  | 7 - 16
  | 3X
|-
  | [[Hyperhomocystenemia]]
  | 5
  | 10
  | 3X
|-
  | Elevated [[factor VIII]] levels
  | 11
  | 25
  | 5X
|-
|}
The table has been adapted from Best Pract Res Clin Obstet Gynaecol. 2003 Jun;17(3):397-411<ref name="pmid12787534">{{cite journal |author=Buchanan GS, Rodgers GM, Ware Branch D |title=The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation |journal=Best Pract Res Clin Obstet Gynaecol |volume=17 |issue=3 |pages=397–411 |year=2003 |month=June |pmid=12787534 |doi= |url=}}</ref> and data has been obtained from references<ref name="pmid11309638">{{cite journal |author=Seligsohn U, Lubetsky A|title=Genetic susceptibility to venous thrombosis |journal=N. Engl. J. Med. |volume=344 |issue=16 |pages=1222–31 |year=2001 |month=April |pmid=11309638|doi=10.1056/NEJM200104193441607 |url=}}</ref><ref name="pmid11702218">{{cite journal |author=Franco RF, Reitsma PH |title=Genetic risk factors of venous thrombosis |journal=Hum. Genet. |volume=109 |issue=4 |pages=369–84 |year=2001 |month=October |pmid=11702218 |doi=10.1007/s004390100593 |url=}}</ref><ref name="pmid7740487">{{cite journal |author=Haverkate F, Samama M |title=Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen |journal=Thromb. Haemost. |volume=73 |issue=1 |pages=151–61 |year=1995 |month=January |pmid=7740487 |doi= |url=}}</ref>.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 13:22, 21 September 2012

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia epidemiology and demographics

CDC on Thrombophilia epidemiology and demographics

Thrombophilia epidemiology and demographics in the news

Blogs on Thrombophilia epidemiology and demographics

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Prevalence of various inherited thrombophilias and their clinical impact

Disorder Healthy subjects/General population (%) Patients with known thrombosis (%) Estimated increase in thrombosis risk
Antithrombin deficiency 0.02 1 - 4 10 - 20X
Dysfibrinogenemia <1 <1 Variable
Protein C deficiency 0.2 - 0.4 3 - 5 10X
Protein S deficiency 0.3 - 0.13 2 - 4 10X
Factor V Leiden 1 - 15 18 - 40 5X
G20210A prothrombin gene mutation 2 - 5 7 - 16 3X
Hyperhomocystenemia 5 10 3X
Elevated factor VIII levels 11 25 5X

The table has been adapted from Best Pract Res Clin Obstet Gynaecol. 2003 Jun;17(3):397-411[1] and data has been obtained from references[2][3][4].

References

  1. ↑ Buchanan GS, Rodgers GM, Ware Branch D (2003). "The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation". Best Pract Res Clin Obstet Gynaecol. 17 (3): 397–411. PMID 12787534. Unknown parameter |month= ignored (help)
  2. ↑ Seligsohn U, Lubetsky A (2001). "Genetic susceptibility to venous thrombosis". N. Engl. J. Med. 344 (16): 1222–31. doi:10.1056/NEJM200104193441607. PMID 11309638. Unknown parameter |month= ignored (help)
  3. ↑ Franco RF, Reitsma PH (2001). "Genetic risk factors of venous thrombosis". Hum. Genet. 109 (4): 369–84. doi:10.1007/s004390100593. PMID 11702218. Unknown parameter |month= ignored (help)
  4. ↑ Haverkate F, Samama M (1995). "Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen". Thromb. Haemost. 73 (1): 151–61. PMID 7740487. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Thrombophilia_epidemiology_and_demographics&oldid=747465"